Wendy C. Weinberg

United States Food and Drug Administration

MedicineImmunology and MicrobiologyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “FDA Approval Summary: Margetuximab plus Chemotherapy for Advanced or Metastatic HER2-Positive Breast Cancer”.

FDA Approval Summary: Margetuximab plus Chemotherapy for Advanced or Metastatic HER2-Positive Breast Cancer

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-3247

N/A

0DataRank · unranked

39 citations

Christy Osgood, Anup Amatya, Mallorie H. Fiero, C.J. George Chang, Tiffany K. Ricks +32 more

Delineating functional mechanisms of the p53/p63/p73 family of transcription factors through identification of protein–protein interactions using interface mimicry

Molecular Carcinogenesis(2022)10.1002/mc.23405

N/A

0DataRank · unranked

3 citations

Nozomi Sakakibara, Roshini M. Ponnamperuma, Kun Dong, H. Matar, Kathryn E. King +2 more

Oncogenic Ras and ΔNp63α cooperate to recruit immunosuppressive polymorphonuclear myeloid-derived suppressor cells in a mouse model of squamous cancer pathogenesis

Frontiers in Immunology(2023)10.3389/fimmu.2023.1200970

N/A

0DataRank · unranked

1 citations

Paúl E. Clavijo, Cem Sievers, Veronica C. Gray, Kathryn E. King, Andrea L. George +7 more